Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present CyberOptics Corp. (NASDAQ: CYBE).

Full DD Report for CYBE

You must become a subscriber to view this report.


Recent News from (NASDAQ: CYBE)

New Research Coverage Highlights Hope, Golden Entertainment, The RMR Group, Piper Jaffray Companies, CyberOptics, and Ameris - Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, May 02, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Hope Bancorp, Inc. (NASDAQ:HOPE), Golden Entertainment, Inc. (NASDAQ:GDEN)...
Source: GlobeNewswire
Date: May, 02 2018 08:30
CyberOptics Corp's (CYBE) CEO Subodh Kulkarni on Q1 2018 Results - Earnings Call Transcript
CyberOptics Corp (CYBE) Q1 2018 Earnings Conference Call April 24, 2018, 09:00 ET Executives Subodh Kulkarni - President, CEO & Director Jeffrey Bertelsen - VP, Finance, CFO, COO & Secretary Analysts Gregory Palm - Craig-Hallum Capital Group Richard Ryan - Dougher...
Source: SeekingAlpha
Date: April, 24 2018 12:11
CyberOptics EPS in-line, beats on revenue
CyberOptics (NASDAQ: CYBE ): Q1 EPS of -$0.02 in-line. Revenue of $14.1M (+18.3% Y/Y) beats by $1.06M . Press Release More news on: CyberOptics Corporation, Earnings news and commentary, Tech stocks news, ,
Source: SeekingAlpha
Date: April, 24 2018 08:32
CyberOptics First Quarter 2018 Earnings Conference Call Scheduled for April 24
CyberOptics® Corporation (NASDAQ: CYBE), a leading global developer and manufacturer of high-precision 3D sensing technology solutions will hold its conference call to review operating results for the first quarter of 2018 on April 24 at 9:00 AM Eastern. The first quarter earnings r...
Source: Business Wire
Date: April, 09 2018 09:00
Chips, Apple suppliers drop on Intel news
Bloomberg’s report that Apple might abandon Intel chips in future Macs is pulling down shares of other chip companies and Apple suppliers. More news on: CyberOptics Corporation, Amkor Technology, Inc., Advanced Micro Devices, Inc., Tech stocks news, Stocks on the move, Read mor...
Source: SeekingAlpha
Date: April, 02 2018 14:28
Consolidated Research: 2018 Summary Expectations for Archrock, Milacron, On Deck Capital, CyberOptics, Verint, and International Seaways - Fundamental Analysis, Key Performance Indications
NEW YORK, March 20, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Archrock, Inc. (NYSE:AROC), Milacron Holdings Corp. (NYSE:MCRN), On Deck...
Source: GlobeNewswire
Date: March, 20 2018 07:55
CyberOptics Industry-Leading MRS-Enabled SE3000(TM) 3D SPI Receives NPI Award
CyberOptics® Corporation (NASDAQ: CYBE), a leading global developer and manufacturer of high-precision 3D sensing technology solutions, today announced that it has been awarded a 2018 NPI Award in the category of Test and Inspection – SPI for its SE3000™ Solder Paste Ins...
Source: Business Wire
Date: February, 28 2018 09:00
CyberOptics (CYBE) CEO Subodh Kulkarni on Q4 2017 Results - Earnings Call Transcript
CyberOptics Corp (CYBE) Q4 2017 Earnings Conference Call February 20, 2018 16:30 ET Executives Jeff Bertelsen - Chief Operating Officer, VP Finance & Chief Financial Officer Subodh Kulkarni - President and Chief Executive Officer Analysts Greg Palm - Craig-Hallum Capital ...
Source: SeekingAlpha
Date: February, 20 2018 22:12
CyberOptics EPS of $0.07
CyberOptics (NASDAQ: CYBE ): Q4 EPS of $0.07 may not be comparable to consensus of -$0.04. Revenue of $13.18M (-2.1% Y/Y) beats by $1.26M . Press Release More news on: CyberOptics Corporation, Earnings news and commentary, Tech stocks news, ,
Source: SeekingAlpha
Date: February, 20 2018 16:01
Dr. Vivek Mohindra Nominated to Stand for Election to CyberOptics Corporation Board of Directors
CyberOptics Corporation (Nasdaq: CYBE) (the Company) today announced that its Board of Directors has nominated Dr. Vivek Mohindra to stand for election as a director at its 2018 Annual Meeting of Shareholders. The Company also announced that Alex Cimochowski has informed the Board of Directo...
Source: Business Wire
Date: February, 20 2018 16:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-2516.3016.4016.5016.1536,340
2018-05-2416.1016.3016.3516.0533,249
2018-05-2316.5016.1016.6016.0046,378
2018-05-2216.4016.6016.6016.3086,779
2018-05-2116.2516.3016.8516.20126,452

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-253,3229,40935.3066Short
2018-05-244,9526,49776.2198Short
2018-05-235,90711,11253.1587Short
2018-05-2211,17846,64823.9624Cover
2018-05-2131,39966,39947.2884Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CYBE.


About CyberOptics Corp. (NASDAQ: CYBE)

Logo for CyberOptics Corp. (NASDAQ: CYBE)

Not available

 

Contact Information

 

 

Current Management

  • Steven M. Quist / President, CEO
  • Jack Beagan / Acting CFO

Current Share Structure

  • Market Cap: $113,501,148 - 05/11/2018
  • Issue and Outstanding: 6,984,686 - 02/28/2018

 


Recent Filings from (NASDAQ: CYBE)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 24 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 04 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 09 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 20 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 09 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 08 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: February, 08 2018

 

 


Daily Technical Chart for (NASDAQ: CYBE)

Daily Technical Chart for (NASDAQ: CYBE)


Stay tuned for daily updates and more on (NASDAQ: CYBE)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CYBE)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

OTC Report
@OTCReporter

 

 


Disclaimer: OTC Report publishes reports providing information on selected companies. OTC Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. OTC Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CYBE is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. OTC Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. OTC Report does not own any shares of CYBE and does not buy, sell, or trade any shares of CYBE. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by OTC Report. All rights reserved. Our Full Disclaimer: http://otc.report/disclaimer/